Answers are grounded in this paper and cite their sources.
Experiment reveals CD49a + T cells improve cytotoxicity in murine kidney grafts, suggesting BHLHE40's role in allograft rejection.
Tissue‐resident memory T cells (T RM ), which function against tumors, infections, and non‐self antigens in organ transplantation, exhibit both effector and memory functionality. However, the homeostasis and differentiation of T RM is not clear. Using a murine kidney transplant model for long‐term observation, our single‐cell and spatial transcriptomics showed that CD49a + PD1 hi CD8 + T RM exhibited an effector phenotype with enhanced cytotoxicity at a later stage. This subset might mature from a CXCR6 hi precursor‐like state with proliferation capacity in tertiary lymphoid structures (TLSs) in allografts. Mechanically, BHLHE40 is required for CD49a + PD1 hi CD8 + T RM differentiation and effector function, thereby driving rejection in allo‐transplantation. In TLSs, TGF‐β orchestrated BHLHE40 expression in T RM and effector T RM differentiation. Our findings identified an effector subset of T RM as CD49a + PD1 hi CD8 + T RM , and highlighted a BHLHE40‐orchestrated, resident immune component, rather than circulating cells, as a major contributor to allograft rejection.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: